Japan unit of Britain’s Jazz Pharma starts phase III trial of cannabis drug
TOKYO, Dec 15 (Reuters) – The Japanese unit of Britain’s
Jazz Pharmaceuticals PLC said on Thursday it had
started a phase III trial of a cannabis-based drug for epilepsy.
The trial follows a recom…